Are thrombotic complications in patients with von Willebrand's disease expression of a multifactorial disease?
Franchini
Massimo
M
Servizio di Immunoematologia e Trasfusione - Centro Emofilia, Azienda Ospedaliera di Verona. massimo.franchini@azosp.vr.it
Salvagno
Gian Luca
GL
Manzato
Franco
F
Lippi
Giuseppe
G
D020413:3' Untranslated Regions / Q000235:genetics; D020016:Activated Protein C Resistance / Q000150:complications* / Q000235:genetics; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip; D000075202:Contraindications; D003327:Coronary Disease / Q000150:complications; D003894:Deamino Arginine Vasopressin; D005165:Factor V / Q000235:genetics; D005169:Factor VIII / Q000627:therapeutic use; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D011183:Postoperative Complications / Q000209:etiology*; D011516:Prothrombin / Q000235:genetics*; D011655:Pulmonary Embolism / Q000209:etiology*; D019851:Thrombophilia / Q000235:genetics*; D014842:von Willebrand Diseases / Q000097:blood / Q000150:complications* / Q000235:genetics; D014841:von Willebrand Factor / Q000627:therapeutic use
D020413:3' Untranslated Regions; D000925:Anticoagulants; C095381:factor V Leiden; D014841:von Willebrand Factor; D005165:Factor V; D011516:Prothrombin; D005169:Factor VIII; D006493:Heparin; D003894:Deamino Arginine Vasopressin